SH Healthcare Investment No.1 Association Amends NGeneBio Shareholding Report by 1 Share Due to 3:1 Reverse Stock Split, Ownership Unchanged at 23%

SH Healthcare Investment No.1 Association has filed an amendment to its substantial shareholding report reflecting the share count changes resulting from NGeneBio's 3:1 reverse stock split effective June 25, 2026.
The amendment corrects a one-share discrepancy in the post-split share count, reducing the reported shares from 2,055,257 to 2,055,256 due to fractional share handling.
While the reverse split reduced total outstanding shares from 26,809,750 to 8,936,583 a 66.7% decrease, the largest shareholder's ownership remains unchanged at 23.00% with no material impact on shareholder value.
[AI Summary]The 3:1 reverse stock split is a defensive measure to address NGeneBio's capital impairment, and as a share consolidation, it does not alter existing shareholders' proportional ownership. This amendment is a minor clerical correction of a single share, carrying no significant financial implications for investors.